Dopl Technologies closes $6.3M seed for telerobotic ultrasound
Dopl Technologies completed a $6.3 million seed round led by SpringTide Ventures to advance its telerobotic ultrasound platform toward FDA submission and initial deployments.
Evidence notes
- The round takes disclosed cumulative funding above $8 million.
- WRF Capital, Tacoma Venture Fund, HeartX, Transform Health Ventures and Precursor Ventures participated.
- Dopl Traverse remains under development and is not yet commercially available.